Cited 10 times in
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.